Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis

NCT00832364 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business decision. No patients were enrolled

Conditions

Plaque Psoriasis

Interventions

DRUG: Acitretin (also called U0279)
DRUG: Placebo
BIOLOGICAL: Etanercept

Sponsor

Stiefel, a GSK Company

Collaborators

[object Object]